Bearing Nspva Embolization Particles
Agents, Embolic, For Treatment Of Uterine Fibroids. 510(k) K130259, from Merit Medical Systems, Inc. (Rockland, MA). Product code NAJ, class 2.
As of Nov 19, 2026, K130259 is an FDA 510(k) held by Merit Medical Systems, Inc., substantially equivalent on Jun 7, 2013 after 126 days, with no recalls tied to it in FDA's recall database.
- Review time: 126 days
- Recalls: 0
- Cited as a predicate by: 1 device
Bearingâ„¢ nsPVA Embolization Particles are used for the embolization of peripheral hypervascularized tumors, including leiomyoma uteri and peripheral arteriovenous malformations (AVMs). Do not use particles smaller than 355 microns for the treatment of leiomyoma uteri.
- Contour Embolization Particles, Models M0017600121, M0017600221, M0017600321K100663 · Boston Scientific Corporation · Apr 16, 2010
- Bearing nsPVA Express™K233813 · Merit Medical Systems, Inc. · Dec 21, 2023
- Bearing nsPVA Express™K233813 · Merit Medical Systems, Inc. · Dec 21, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 1, 2013
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.3300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files